World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
122
Citations
57484
World Ranking
315
National Ranking
199

Medicine

D-Index
128
Citations
60897
World Ranking
2713
National Ranking
1516

Raymond T. Chung publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Raymond T. Chung sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 781 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Raymond T. Chung D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Raymond T. Chung sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 122 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Raymond T. Chung is affiliated with Harvard University in the United States. Their research primarily focuses on the field of Medicine, with significant contributions to Hepatology, Epidemiology, Molecular Biology, Immunology, and Infectious Diseases.

Their recent scientific output includes papers published in notable venues such as Hepatology, Frontiers in Neuroscience, and Cell. Some of the most cited papers are:

  • Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement (2020), Hepatology
  • Liver Biochemistries in Hospitalized Patients With COVID-19 (2020), Hepatology
  • The Developing Human Connectome Project Neonatal Data Release (2022), Frontiers in Neuroscience
  • American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease (2021), Hepatology
  • A MicroRNA Linking Human Positive Selection and Metabolic Disorders (2020), Cell

The frequent co-authors associated with this researcher include Charles Curtis, Sang Hyuck Lee, Patricia P. Bloom, Gerome Breen, and Catherine Smith. These collaborations have contributed to advancing knowledge in their fields of study.

Publication venues where the researcher has been active include bioRxiv (Cold Spring Harbor Laboratory), Hepatology Communications, SSRN Electronic Journal, Hepatology, and the Journal of Investigative Dermatology.

Their work covers multiple research topics with a particular emphasis on:

  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • COVID-19 Clinical Research Studies
  • Asthma and respiratory diseases
  • SARS-CoV-2 and COVID-19 Research
  • Hepatitis B Virus Studies
  • Psoriasis: Treatment and Pathogenesis

Raymond T. Chung has contributed to a body of research that intersects clinical hepatology and infectious diseases, with specific interest in liver-related complications arising during the COVID-19 pandemic. Their publication record demonstrates engagement with both clinical and molecular facets of disease, reflected in studies ranging from liver biochemistry in infected patients to vaccine strategies for individuals with liver disease.

Best Publications

  • Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States

    George Ostapowicz;Robert J. Fontana;Frank V. Schioødt;Anne Larson

  • A role for hepatitis C virus infection in type II cryoglobulinemia.

    Vincent Agnello;Raymond T. Chung;Lee M. Kaplan

  • Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus

    F. Lechner;D. K. H. Wong;P. R. Dunbar;R. Chapman

  • Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.

    Jodie L Babitt;Franklin W Huang;Diedra M Wrighting;Yin Xia

  • Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.

    Raymond T. Chung;Janet Andersen;Paul Volberding;Gregory K. Robbins

  • Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant.

    Zachariah DeFilipp;Patricia P. Bloom;Mariam Torres Soto;Michael K. Mansour

  • Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group

    Kenneth E. Sherman;Susan D. Rouster;Raymond T. Chung;Natasa Rajicic

  • The epigenetic landscape of T cell exhaustion

    Debattama R. Sen;James Kaminski;R. Anthony Barnitz;Makoto Kurachi

  • Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

    Raymond T. Chung;Marc G. Ghany;Arthur Y. Kim;Kristen M. Marks

  • A TALEN Genome-Editing System for Generating Human Stem Cell-Based Disease Models

    Qiurong Ding;Youn-Kyoung Lee;Esperance Anne Kreek Schaefer;Derek Tilghman Peters

  • Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis

    Yingying Yu;Yingying Yu;Yingying Yu;Li Jiang;Hao Wang;Zhe Shen

  • Comprehensive serological profiling of human populations using a synthetic human virome

    George J. Xu;Tomasz Kula;Tomasz Kula;Qikai Xu;Qikai Xu;Mamie Z. Li;Mamie Z. Li

  • A Functional Genomic Screen Identifies Cellular Cofactors of Hepatitis C Virus Replication

    Andrew W. Tai;Yair Benita;Lee F. Peng;Sun Suk Kim

  • Serum alpha-fetoprotein levels in patients with advanced hepatitis C: Results from the HALT-C Trial☆

    Adrian M. Di Bisceglie;Richard K. Sterling;Raymond T. Chung;James E. Everhart

  • Circulating Mitochondrial DNA in Patients in the ICU as a Marker of Mortality: Derivation and Validation

    Kiichi Nakahira;Sun-Young Kyung;Angela J. Rogers;Lee Gazourian

  • NATURALLY OCCURRING DOMINANT RESISTANCE MUTATIONS TO HEPATITIS C VIRUS PROTEASE AND POLYMERASE INHIBITORS IN TREATMENT-NAIVE PATIENTS

    Thomas Kuntzen;Joerg Timm;Andrew Berical;Niall Lennon

  • Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID-19 Pandemic: AASLD Expert Panel Consensus Statement.

    Oren K. Fix;Bilal Hameed;Robert J. Fontana;Ryan M. Kwok

  • Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis

    Xiaobo Wang;Ze Zheng;Jorge Matias Caviglia;Kathleen E. Corey

  • Outcomes in adults with acute liver failure between 1998 and 2013: An observational cohort study

    Adrian Reuben;Holly Tillman;Robert J. Fontana;Timothy Davern

  • High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection

    Georg M. Lauer;Eleanor Barnes;Eleanor Barnes;Michaela Lucas;Joerg Timm

  • Sofosbuvir and Ribavirin Prevent Recurrence of HCV Infection After Liver Transplantation: An Open-Label Study

    Michael P. Curry;Xavier Forns;Raymond T. Chung;Norah A. Terrault

  • CD8 Epitope Escape and Reversion in Acute HCV Infection

    Joerg Timm;Georg M. Lauer;Daniel G. Kavanagh;Isabelle Sheridan

Frequent Co-Authors

Arthur Y. Kim
Arthur Y. Kim Harvard University
Georg M. Lauer
Georg M. Lauer Harvard University
William M. Lee
William M. Lee The University of Texas Southwestern Medical Center
Bruce D. Walker
Bruce D. Walker Harvard University
Robert J. Fontana
Robert J. Fontana University of Michigan–Ann Arbor
Todd M. Allen
Todd M. Allen Harvard University
Kenneth E. Sherman
Kenneth E. Sherman University of Cincinnati Medical Center
Marion G. Peters
Marion G. Peters University of California, San Francisco
David E. Kleiner
David E. Kleiner National Institutes of Health
Marc G. Ghany
Marc G. Ghany National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can enhance your career prospects. Many students explore nursing pathways that complement immunological knowledge, such as Licensed Practical Nurse (LPN) programs. To find accessible options, consider exploring which lpn programs are easiest to get into, helping you start your healthcare career efficiently.

Advanced nursing roles, like Nurse Practitioners, often collaborate closely with immunologists in patient care. If flexibility is important, there are numerous easiest online nurse practitioner programs that provide convenient avenues to earn your degree without compromising quality.

Mental health also intersects with immunology in areas like psychiatric disorders. Programs offering specialization in psychiatric mental health nursing, such as the best online pmhnp programs, provide excellent clinical placement opportunities essential for hands-on experience.

Cost is a critical consideration. If budget constraints are a factor, exploring cheapest online pmhnp certificate programs can make advanced psychiatric nursing education more attainable while maintaining a strong foundation in care.

By combining immunology expertise with nursing qualifications, graduates can open doors to diverse and impactful healthcare roles, enhancing patient outcomes across various settings.

Best Scientists Citing Raymond T. Chung

Trending Scientists

Recently Published Articles